Aura Biosciences, Inc. (AURA): Price and Financial Metrics
AURA Price/Volume Stats
| Current price | $8.20 | 52-week high | $12.38 |
| Prev. close | $8.11 | 52-week low | $6.63 |
| Day low | $8.01 | Volume | 612,400 |
| Day high | $8.43 | Avg. volume | 182,930 |
| 50-day MA | $9.69 | Dividend yield | N/A |
| 200-day MA | $8.41 | Market Cap | 409.60M |
AURA Stock Price Chart Interactive Chart >
Aura Biosciences, Inc. (AURA) Company Bio
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
AURA Price Returns
| 1-mo | -9.19% |
| 3-mo | -14.32% |
| 6-mo | 15.33% |
| 1-year | -5.96% |
| 3-year | -46.48% |
| 5-year | N/A |
| YTD | -7.45% |
| 2023 | -15.62% |
| 2022 | -38.16% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...